A major new review connects NAD+ depletion with both photoageing and non-melanoma skin cancer. Its conclusion is measured: nicotinamide biology is compelling, but better skin-focused studies are needed. Limeway’s response is that formulation science may be the bridge between the two. By Dr Adrian Davis, Chief Scientific Officer, Limeway Pharma Read more
A delivery-first approach to topical NAD⁺ skincare. In Part 1, we explored a central challenge for topical NAD⁺ skincare: an ingredient cannot work in the skin unless it reaches the right site, at the right concentration, for long enough to matter. This is why Limeway Pharma Design has focused on Read more
The next generation of skin longevity products will be defined by delivery science — not ingredient novelty alone. NAD⁺ has become one of the most important themes in longevity science. It is central to cellular energy, mitochondrial function, DNA repair and many of the biological processes associated with ageing, repair Read more